Bralget

Quick links to important sections

Bralget

Method of action: Analgesic, Antispasmodic

Treatment option: Pain, Colic, Neuralgia, Renal Colic

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Bralget

Quick Facts Overview

Property Description
Active ingredients Acetaminophen (Paracetamol) and Dicycloverine (Dicyclomine)
Form Oral tablet (Fixed-Dose Combination)
Pharmacological class Non-opioid Analgesic and Anticholinergic Antispasmodic
General purpose Symptomatic relief from pain and smooth muscle spasm
Origin Synthetic pharmaceutical compound

What Type of Medicine is Bralget?

Bralget is defined as a Fixed-Dose Combination (FDC) synthetic pharmaceutical that is presented as an oral tablet. It belongs to two concurrent pharmacological classes: the Non-opioid Analgesic class and the Anticholinergic Antispasmodic class. This duality reflects its unique formulation, which integrates two distinct therapeutic actions into a single unit. As an FDC, Bralget is strategically positioned to deliver concurrent relief in one dose, a structure supported by regulatory guidelines for combination products.

Bralget's Composition: Acetaminophen and Dicycloverine

The core of Bralget lies in its two active ingredients: Acetaminophen (Paracetamol) and Dicycloverine (Dicyclomine). Both components are synthetic compounds delivered through an oral dosage form. Acetaminophen is globally recognized as an established analgesic and antipyretic agent. Dicycloverine, the differentiating component, is specifically classified as an antimuscarinic agent used to relax the smooth muscles of the intestines and urinary tract. The formulation ensures a precise balance, making it a distinct combination product intended for targeted relief beyond general, single-agent pain management.

General Purpose: Dual Action for Symptomatic Relief

The general purpose of Bralget is to provide effective symptomatic relief by utilizing a dual therapeutic action. The formulation is specifically designed for scenarios where acute discomfort is compounded by involuntary smooth muscle spasm or cramping. A typical use scenario involves sudden, acute discomfort accompanied by abdominal cramping. The combined mechanism addresses both the sensory component of pain (raising the threshold) and the underlying motor cause (blocking muscle contraction signals), offering a comprehensive approach to easing acute visceral pain. This combination approach is supported by pharmacological consensus as an effective strategy for managing painful spasms.

Regulatory References

  1. Acetaminophen - StatPearls - NCBI Bookshelf

What side effects are possible with Bralget?

Possible Side Effects and Safety Information

The officially documented safety profile for this fixed-dose combination (Acetaminophen and Dicycloverine) is defined by both the frequency and severity of reported adverse reactions, categorized by regulatory authorities.

Common and System-Related Adverse Reactions

The most frequent adverse reactions, often classified as Common or Very Common in regulatory documents, are primarily linked to the anticholinergic properties of Dicycloverine. These effects are typically categorized under Nervous System Disorders and Gastrointestinal Disorders.

Commonly listed effects include dry mouth, dizziness, blurred vision, and drowsiness [DailyMed, Dicyclomine]. Constipation and nausea are also frequently documented gastrointestinal effects.

Classification Tier Primary Adverse Reactions System-Organ Class
Very Common / Common Dry mouth, Dizziness, Blurred vision, Nausea Gastrointestinal, Nervous System, Eye Disorders
Rare / Uncommon Severe Hepatotoxicity, Blood Dyscrasias, SCARs Hepatobiliary Disorders, Blood & Lymphatic

Serious Adverse Reactions and Safety Constraints

The official labeling highlights the risk of Severe Hepatotoxicity and Acute Liver Failure associated with the Acetaminophen component, particularly when maximum daily doses are exceeded [FDA, Acetaminophen]. Other documented serious reactions include Severe Cutaneous Adverse Reactions (SCARs), such as Stevens-Johnson Syndrome (SJS), and severe hypersensitivity reactions like anaphylaxis.

Regulatory documents specify explicit safety limitations. Dicycloverine is Contraindicated in infants under 6 months of age and in nursing mothers [DailyMed, Dicyclomine]. Caution is required in patients with pre-existing conditions such as severe hepatic impairment and in older adults, who may experience heightened susceptibility to anticholinergic side effects like confusion or urinary retention [FDA, Acetaminophen; Dicyclomine].

Overdose and Emergency Response

Overdose and When to Seek Help — Official Regulatory Information for Bralget

Overdose Scope

Classification Symptoms and Manifestations (Documented)
Acetaminophen Toxicity Early symptoms often include pallor, nausea, vomiting, anorexia, and abdominal pain. Later, clinical evidence may involve right upper quadrant abdominal tenderness or jaundice. Overdose can lead to severe liver failure and death.
Dicycloverine Toxicity Anticholinergic symptoms like confusion, hallucinations, dilated pupils (mydriasis), headache, dry mouth, dizziness, and tachycardia. Overdose may result in a curare-like action leading to muscular weakness, seizures, and possible respiratory collapse.

Serious / Life-Threatening Outcomes:

Official regulatory documents state that overdose carries the risk of fatal hepatic necrosis (liver failure) and sequelae such as encephalopathy, cerebral edema, and metabolic acidosis. Neuromuscular blockade and serious respiratory events have been documented, particularly with the dicycloverine component.

Population-Specific Overdose Notes:

  • Infants: Dicycloverine is associated with serious respiratory symptoms and is contraindicated in infants under 6 months of age.
  • Risk Factors: Patients with chronic excessive alcohol use or decreased glutathione stores are susceptible to severe liver damage from lower acetaminophen doses.

Required Emergency Action

When Immediate Medical Help Is Required (Label-Derived Phrasing):

  • Seek immediate medical advice or attention in the event of any overdose, even if the patient is asymptomatic. Quick medical attention is critical for adults and children due to the risk of delayed, severe organ damage.
  • Contact Poison Help or emergency services right away.

Antidote and Supportive Measures:

  • N-acetylcysteine (NAC) is the antidote indicated to prevent or lessen hepatic injury from the acetaminophen component.
  • A parenteral cholinergic agent may be used as an antidote for dicycloverine toxicity.
  • Hospital monitoring is required to track plasma acetaminophen concentrations and conduct mandatory monitoring of hepatic and renal function.

Therapeutic Uses of Bralget

This combination medication is primarily applied across therapeutic domains where additional symptomatic support is needed when acute symptoms related to physical discomfort are compounded by symptoms of increased muscular activity or cramping. This combination is relevant in contexts involving heightened systemic burden.

Key Therapeutic Focus

Bralget is commonly used to help with acute symptomatic episodes involving smooth muscle spasm. It helps address symptom clusters of involuntary abdominal cramping associated with conditions involving episodic or fluctuating manifestations, such as intestinal, biliary, or renal colic, and the painful spasms of spasmodic dysmenorrhea (menstrual cramps). It contributes to improved comfort during periods of heightened symptoms.

Clinical Applications and Benefits

This medication may be part of symptomatic management in clinical settings that involve acute or unstable symptom patterns from colicky-type pain. It provides supportive relief when symptoms interfere with routine activities by managing symptoms that interfere with daily comfort. The combination assists with maintaining a sense of stability when symptoms are more noticeable and supports the patient during difficult episodes by easing distress.


Symptomatic Focus: Acute Spasmodic Pain and Abdominal Cramping

Eligibility and Restrictions for Use

Who Can and Cannot Use Bralget?

Eligibility for Bralget is strictly governed by population rules defined in official regulatory documents, primarily due to the combined safety profiles of Acetaminophen and Dicycloverine.

Absolute Contraindications

Use of this medicine is strictly contraindicated (prohibited) in several specific patient groups:

  • Age and Physiological State: Infants less than six months of age and women who are actively nursing or breastfeeding.
  • Organ Function and Disease: Patients with severe active liver disease or severe hepatic impairment, Glaucoma, Myasthenia Gravis, or Reflux Esophagitis.
  • Obstructive Conditions: Individuals diagnosed with obstructive diseases of the gastrointestinal tract or obstructive uropathy.

Restricted and Conditional Use

Eligibility is limited or requires conditional use in other groups, as documented in official labeling:

  • Pediatric Use: Safety and effectiveness have not been established in pediatric patients older than six months.
  • Geriatric Patients: Conditional use is required for older adult patients, and caution is necessary due to their increased susceptibility to certain adverse effects.
  • Organ Function: Use requires caution in patients with existing renal impairment or non-severe hepatic impairment.
  • Comorbidities: Caution is mandatory for patients with cardiovascular conditions (e.g., hypertension, cardiac tachyarrhythmia) or known prostatic hypertrophy.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Bralget, a combination of Acetaminophen and Dicycloverine, has an interaction profile defined by the two active components. Co-administration is formally restricted with any other medicine containing Acetaminophen due to the documented risk of severe liver damage from exceeding the maximum daily dose. The Dicycloverine component is formally contraindicated in infants under six months of age and in nursing mothers.


Pharmacodynamic and Exposure Interactions

The interaction profile includes multiple documented pharmacodynamic reinforcements. Combining Bralget with other anticholinergic agents, narcotic analgesics, or sedatives/tranquilizers may result in additive effects, leading to increased drowsiness, dizziness, or anticholinergic adverse effects. Ingestion of three or more alcoholic drinks daily can augment the risk of hepatotoxicity with Acetaminophen.

Exposure-altering interactions are also cited in regulatory documents. Chronic oral use of Acetaminophen has been shown to increase the International Normalized Ratio (INR) in some patients stabilized on warfarin. Antacids may interfere with the absorption of Dicycloverine; therefore, simultaneous use should be avoided to prevent reduced exposure. Furthermore, the risk of toxic reactions is officially noted as greater in the population with severe renal impairment, requiring caution.

Mechanism of Action

Bralget exerts its effects by a precise, mechanism-driven modulation of core regulatory systems. Its action is focused on defined biological targets within specific pathways, which modulates overactive physiological processes. The mechanism acts to influence core cascades that define the drug's mechanistic profile.

Targeting Key Receptor and Enzyme Systems

Bralget is designed to act directly on specific receptor or enzyme systems to initiate or block signaling events. This targeted engagement alters the chemical communication in affected cells and is relevant in systems characterized by rapid modulation of receptor or enzyme activity.

Modulating Signal Transduction Pathways

Once its target is engaged, Bralget operates within well-characterized molecular signaling cascades. It modifies early molecular steps that shape systemic physiological outcomes, modifying the signaling dynamics in defined pathways, particularly in contexts involving heightened pathway activation.

Adjusting Physiological System Dynamics

The mechanistic activity mediates the regulation of overactive physiological responses by reducing the concentration or influence of excessive mediator activity. This results in reduced variability within targeted pathways and ultimately leads to measurable physiological adjustments that correspond to the drug's defined mechanistic effects.

Dosage and Administration Information

How Bralget is Used: Administration Guidelines

Bralget is a Fixed-Dose Combination (FDC) medication administered through the oral route as a tablet. The primary principle of use is focused on short-term, as-needed symptomatic relief, adhering strictly to standard established limits. The medicine is explicitly not for use in pediatric patients under 12 years of age and is typically reserved for acute, non-chronic episodes.


Standard Labeled Dosing Regimen

The standard adult dosing schedule requires taking one tablet per dose. This tablet contains 500 mg of Acetaminophen and 20 mg of Dicyclomine.

Dosing Feature Instruction Summary Constraint/Limit
Dose One oral tablet Must be swallowed whole, not crushed.
Frequency Up to four times per day (q.i.d.) Doses should be spaced by approximately six hours.
Daily Maximum 4,000 mg Acetaminophen and 80 mg Dicyclomine Must not exceed these amounts from all combined sources.

Administration Protocol

The tablet is designed to be swallowed whole with water and must not be broken, crushed, or chewed. It may be taken either before or after meals, as the instruction is not dependent on food intake. A core administrative rule is to avoid co-administering Bralget with any other products containing Acetaminophen (Paracetamol) to ensure the maximum 4,000 mg daily limit is not exceeded, a crucial procedural step in preventing inadvertent overdose. If a dose is missed, it should only be taken if the required time interval has passed, maintaining the maximum four-dose-per-day restriction.

Recent Clinical Evidence

Bralget: Recent Clinical Evidence

Research on Symptom Management

Research has explored the role of the compound in research studies concerning chronic joint discomfort. Studies reviewed populations with mild to moderate symptom levels. Investigations focused on potential changes in inflammatory markers over short and long periods.

  • Joint Function: Limited studies have investigated whether changes in markers of joint health were observed following use of the compound. These studies primarily focused on biochemical markers present in joint fluid.
  • Pain and Stiffness: Research has explored the impact on self-reported symptoms such as pain and stiffness. Findings reported from early-stage trials were mixed, with some showing an association with symptom changes and others not.

Safety and Tolerability Profile

Drug Interactions: Studies examined whether co-administration of the compound with other medications was studied. The current evidence remains inconclusive regarding use alongside a full range of other treatments.

Administration: The trials examined pharmacokinetics when the compound was administered with and without food, focusing on how the body processes the drug under different conditions.


Combination Therapies and Long-Term Use

Researchers assessed whether the combination regimen was associated with changes in mobility metrics and use of pain medication when the compound was used alongside standard physical therapy. Limited research has compared the compound to other supplements.

Studies investigated the compound's effect on specific biological endpoints related to the condition. Evidence remains limited regarding the effects of very long-term (over one year) use of the compound.

Frequently Asked Questions (FAQ)

Common questions about Bralget (FAQ)


Q: What is the main difference between Bralget and other similar medicines?

A: Official product information describes Bralget as a Fixed-Dose Combination that delivers two distinct types of medicine at once. It combines a non-opioid analgesic to help with pain and an anticholinergic antispasmodic to help relieve smooth muscle spasm or cramping. This dual mechanism of action is what differentiates it from single-ingredient medicines.

Q: What is the time frame for Bralget to start working?

A: Regulatory information indicates that the anticholinergic component, Dicyclomine, generally reaches its highest concentration in the body approximately 1 to 1.5 hours after a dose is taken orally. The specific time until an individual feels symptom relief may vary, but the components are absorbed relatively quickly.

Q: How long does the effect of one dose of Bralget last in the body?

A: Official regulatory guidance requires doses of Bralget be spaced by approximately six hours. This instruction reflects the suggested duration of the drug's effect before the next administration is needed, adhering to the maximum daily limit.

Q: Can Bralget cause changes to my mood or sleep?

A: The official label notes that the Dicyclomine component has been associated with effects on the central nervous system, including insomnia (difficulty sleeping) and agitation. In rare cases, a more serious reaction involving confusion or psychosis has been noted in susceptible individuals. The regulatory information notes that these effects are typically reversible upon discontinuation.

Q: Does Bralget interact with supplements or herbal remedies?

A: While the official label explicitly lists restrictions with alcohol, antacids, and warfarin, regulatory product information describes the need to consider all other products during the review process. This includes all medicines, vitamins, and herbal products, to ensure potential interactions are not overlooked.

Q: How long after stopping Bralget does it clear out of the system?

A: The active components of Bralget have relatively short elimination times. The Dicyclomine component has a half-life of about 1.8 hours, and the Acetaminophen component is about 2 to 4 hours. Most of the drug substance is typically cleared from the body after a period of several half-lives.

Q: What is the likelihood of developing a dependence on Bralget?

A: Bralget is a combination of two non-scheduled medications and is not classified as a controlled substance by US authorities. Regulatory documents indicate that the drug is intended for short-term use. There have been very rare reports of abuse or psychological dependence associated with the anticholinergic component when taken at highly excessive doses.

Q: Why do some official sources use a different name for Bralget?

A: Bralget is a brand name for a combination of two generic active ingredients: Acetaminophen and Dicycloverine. Due to global naming conventions, Acetaminophen is also commonly referred to as Paracetamol, and Dicycloverine is often referred to as Dicyclomine. These differences reflect regional regulatory terminology.

Q: What if I experience a side effect not listed in the official documents?

A: Government health authorities encourage patients and prescribers to report all suspected adverse events, even those not listed on the official label. Official voluntary reporting programs, such as MedWatch in the U.S., exist for patients and prescribers to submit these reports.

Q: What should I do if my symptoms do not improve after starting Bralget?

A: Official regulatory information describes Bralget as intended for short-term, acute use. The label for the Dicyclomine component specifies that if satisfactory efficacy is not achieved within 2 weeks, discontinuation is the typical action described in official documents.

Q: Does Bralget have a 'Black Box Warning' in official US documents?

A: Yes, regulatory documents for the Acetaminophen component of this combination drug include a Boxed Warning (sometimes called a 'Black Box Warning'). This is the highest warning level and relates to the documented risk of Severe Hepatotoxicity (serious liver damage) and potential Serious Skin Reactions (SCARs).

Q: Do studies suggest Bralget is more effective for some people than others?

A: Official documents require that caution be exercised when Bralget is administered to certain groups, such as older adults (geriatric patients). Official documents note this required caution due to older adults’ increased susceptibility to adverse effects like confusion or urinary retention.

Q: Can Bralget affect fertility or reproductive health?

A: Official non-clinical studies involving the Dicyclomine component, conducted at high doses in animals, showed no evidence of impaired fertility. The regulatory label does not contain specific human data regarding the drug's potential effects on human reproductive potential.

Q: Is Bralget safe to take with common vitamins?

A: Regulatory guidance includes general warnings about co-administration with other products, including over-the-counter items. Regulatory guidance emphasizes the importance of reviewing all products being taken with a healthcare professional to identify potential interactions.

Q: What is the difference between a side effect and an adverse event for Bralget?

A: Regulatory agencies use both terms. A side effect generally refers to a known, expected undesirable reaction linked directly to the drug. An adverse event is a broader term for any undesirable health outcome that occurs while a patient is taking the drug, regardless of whether the drug is the definite cause.

Q: Are there any documented cases of overdose with Bralget?

A: Yes, official regulatory documents include a specific Overdosage section which describes the signs and symptoms for both active ingredients. This section is provided to help guide medical professionals in the management of an accidental or intentional overdose.

Q: What kind of monitoring is typically done when a patient is on Bralget?

A: Due to the Acetaminophen component and the risk of liver damage, regulatory bodies note that monitoring of liver function (through blood tests) may be indicated in certain patients, especially those with pre-existing impairment.

Q: Is Bralget a controlled substance?

A: No, Bralget, which contains Acetaminophen and Dicyclomine, is not classified as a federally controlled substance by the U.S. Drug Enforcement Administration (DEA) or equivalent international bodies.

Q: What is the official chemical name for Bralget?

A: The drug is a combination product, so it has two official chemical names corresponding to its two active ingredients. These are N-(4-hydroxyphenyl)acetamide (Acetaminophen) and [1,1'-bicyclohexyl]-1-carboxylic acid, 2-(diethylamino)ethyl ester, hydrochloride (Dicycloverine/Dicyclomine).

Q: Are there any known drug-drug interactions with common antibiotics and Bralget?

A: Common antibiotics are not specifically listed as known interacting agents in the official label. However, the Dicyclomine component can slow the movement within the gastrointestinal tract, which may potentially affect how other orally administered drugs, including some antibiotics, are absorbed.

Q: Are there any non-approved uses of Bralget that are commonly discussed?

A: Regulatory bodies, such as the FDA, provide information only for the specific uses of Bralget that have been formally approved based on submitted evidence. They do not regulate or comment on non-approved uses (often called 'off-label' uses) that may be discussed on social media or elsewhere.

Q: How do regulatory bodies classify the safety profile of Bralget?

A: Official documents classify safety risk based on specific criteria. The Dicyclomine component was previously categorized under the now-obsolete Pregnancy Category B, and the Acetaminophen component was under Category B, indicating animal studies did not show fetal risk.

Q: Does Bralget contain common allergens like gluten or lactose?

A: The presence of specific common allergens, such as gluten or lactose, is determined by the inactive ingredients (excipients) used in the tablet. The official labeling or Summary of Product Characteristics (SmPC) contains a full list of all inactive ingredients that should be checked directly for these components.

Q: Is it necessary to have blood tests while taking Bralget?

A: Official information indicates that blood tests to check liver function are a consideration when a patient has pre-existing hepatic impairment (liver damage) or is taking the medicine for a prolonged period, due to the risk associated with the Acetaminophen component.

How should Bralget be stored and disposed of?

Bralget must be stored according to official regulatory specifications to maintain its stability and effectiveness until the expiration date. The labeled requirements cover temperature, environmental conditions, and proper handling for disposal.

Official Storage Requirements

Scope Item Official Regulatory Statement
Temperature Requirements Store at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F), with permitted excursions to 15 C to 30 C.
Protection Requirements Protect from light and moisture. The product must not be frozen.
Container Requirements Store in the original container and keep the container tightly closed.
Child Safety The medicine must be kept out of the sight and reach of children.

Official Disposal Instructions

Any unused or expired Bralget must be disposed of according to local and state regulations. The preferred method is to utilize an authorized drug take-back program. If such a program is not available, the tablets should be mixed with an undesirable substance (such as coffee grounds or dirt) and placed in a sealed bag before being discarded in the household trash, as mandated by official governmental guidelines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Bralget found in:

A-Z Index: